Royce & Associates LP Sells 23,599 Shares of Semler Scientific, Inc. (OTCMKTS:SMLR)

Royce & Associates LP lessened its position in Semler Scientific, Inc. (OTCMKTS:SMLR – Get Rating) by 50.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 23,171 shares of the medical equipment provider’s stock after selling 23,599 shares during the period. Royce & Associates LP owned about 0.34% of Semler Scientific worth $1,148,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in SMLR. Qube Research & Technologies Ltd bought a new position in shares of Semler Scientific in the fourth quarter worth approximately $958,000. Advisor Group Holdings Inc. lifted its position in Semler Scientific by 296.5% during the fourth quarter. Advisor Group Holdings Inc. now owns 448 shares of the medical equipment provider’s stock valued at $42,000 after purchasing an additional 335 shares during the period. Redmond Asset Management LLC bought a new position in Semler Scientific during the fourth quarter valued at approximately $828,000. Envestnet Asset Management Inc. bought a new position in Semler Scientific during the fourth quarter valued at approximately $201,000. Finally, Northern Trust Corp lifted its position in Semler Scientific by 72.3% during the fourth quarter. Northern Trust Corp now owns 20,079 shares of the medical equipment provider’s stock valued at $1,840,000 after purchasing an additional 8,423 shares during the period. Institutional investors own 44.69% of the company’s stock.

Semler Scientific Price Performance

Shares of OTCMKTS SMLR opened at $43.71 on Friday. The firm has a fifty day moving average price of $30.26 and a 200-day moving average price of $45.00. The stock has a market cap of $296.92 million, a PE ratio of 27.15 and a beta of 0.89. Semler Scientific, Inc. has a 1 year low of $27.02 and a 1 year high of $153.21.

Analyst Ratings Changes

Separately, B. Riley lowered their price objective on shares of Semler Scientific from $70.00 to $60.00 in a research report on Tuesday, May 3rd.

About Semler Scientific

(Get Rating)

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.